This page shows Burzynski Resh Inst Inc (BZYR) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Based on FY2025 annual data, averaged across the last 3 years for performance metrics (most-recent year weighted highest). How this score is calculated →
Health score ≠ stock price. This rates the quality of Burzynski Resh Inst Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Burzynski Resh Inst Inc has a moderate D/E ratio of -1.02. This balance of debt and equity financing earns a leverage score of 44/100.
Key Financial Metrics
Earnings & Revenue
Burzynski Resh Inst Inc generated $0 in revenue in fiscal year 2025.
Burzynski Resh Inst Inc earned $-0.01 per diluted share (EPS) in fiscal year 2025. This represents an increase of 0.0% from the prior year.
Cash & Balance Sheet
Burzynski Resh Inst Inc held $847 in cash against $0 in long-term debt as of fiscal year 2025.
Burzynski Resh Inst Inc had 131M shares outstanding in fiscal year 2025. This represents an increase of 0.0% from the prior year.
Margins & Returns
Capital Allocation
BZYR Income Statement
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | $0 | N/A | N/A | N/A | $0 | N/A |
| Cost of Revenue | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| R&D Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Interest Expense | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Income Tax | $0 | $0 | $0 | N/A | $0 | $0 | $0 | N/A |
| Net Income | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 | N/A | $0.00 | $0.00 | $0.00 | N/A |
BZYR Balance Sheet
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $2K+70.2% | $1K-12.5% | $2K+79.6% | $847+18.8% | $713-55.9% | $2K+62.1% | $997-56.8% | $2K |
| Current Assets | $2K+70.2% | $1K-12.5% | $2K+79.6% | $847+18.8% | $713-55.9% | $2K+62.1% | $997-56.8% | $2K |
| Cash & Equivalents | $2K+132.5% | $931+13.4% | $821-3.1% | $847+38.2% | $613-49.6% | $1K+309.4% | $297-77.3% | $1K |
| Inventory | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Accounts Receivable | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Goodwill | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Liabilities | $70K-1.8% | $71K-0.5% | $71K+67.7% | $42K+92.8% | $22K-75.3% | $89K-30.7% | $129K+369.7% | $27K |
| Current Liabilities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Total Equity | -$67K+3.2% | -$70K+0.2% | -$70K-67.4% | -$42K-95.2% | -$21K+75.7% | -$88K+31.5% | -$128K-409.0% | -$25K |
| Retained Earnings | -$130.5M-0.3% | -$130.1M-0.3% | -$129.8M-0.3% | -$129.5M-0.2% | -$129.2M-0.3% | -$128.8M-0.3% | -$128.5M-0.3% | -$128.1M |
BZYR Financial Ratios
| Metric | Q3'26 | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Debt-to-Equity | -1.03-0.0 | -1.020.0 | -1.020.0 | -1.02+0.0 | -1.03-0.0 | -1.02-0.0 | -1.01+0.1 | -1.09 |
| FCF Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Note: Shareholder equity is negative (-$42K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.
Frequently Asked Questions
What is Burzynski Resh Inst Inc's annual revenue?
Burzynski Resh Inst Inc (BZYR) reported $0 in total revenue for fiscal year 2025. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
What are Burzynski Resh Inst Inc's total assets?
Burzynski Resh Inst Inc (BZYR) had $847 in total assets as of fiscal year 2025, including both current and long-term assets.
What is Burzynski Resh Inst Inc's debt-to-equity ratio?
Burzynski Resh Inst Inc (BZYR) had a debt-to-equity ratio of -1.02 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
Why is Burzynski Resh Inst Inc's debt-to-equity ratio negative or unusual?
Burzynski Resh Inst Inc (BZYR) has negative shareholder equity of -$42K as of fiscal year 2025, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.
How financially healthy is Burzynski Resh Inst Inc?
Burzynski Resh Inst Inc (BZYR) scores 7 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks. Learn more in our complete guide to financial health indicators.